Lexeo Therapeutics Inc. C... (LXEO)
5.46
-0.34 (-5.86%)
At close: Jan 15, 2025, 3:59 PM
5.49
0.55%
After-hours Jan 15, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 |
| PE Ratio | -5.39 | -4.18 | -4.9 | -48.11 |
| PS Ratio | n/a | 379.08 | 149.62 | 478.17 |
| PB Ratio | 3.15 | -2.19 | -4.46 | -44.78 |
| P/FCF Ratio | -5.99 | -4.47 | -5.59 | -79.12 |
| P/OCF Ratio | -6.01 | -4.54 | -5.61 | -79.12 |
| OCF/S Ratio | n/a | -83.43 | -26.66 | -6.04 |
| Debt / Equity Ratio | 0.10 | -0.12 | n/a | -0.54 |
| Quick Ratio | 7.21 | 5.58 | 18.35 | 42.15 |
| Current Ratio | 7.21 | 5.58 | 18.35 | 42.15 |
| Asset Turnover | n/a | 0.01 | 0.01 | 0.02 |
| Interest Coverage | -334.21 | -664.93 | n/a | -31.18 |
| Return on Equity (ROE) | -0.58 | 0.52 | 0.91 | 0.93 |
| Return on Assets (ROA) | -0.47 | -0.61 | -0.37 | -0.18 |
| Return on Capital (ROIC) | -0.56 | -0.73 | -0.39 | -0.16 |
| Dividend Yield | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | -75.08% | 99.19% | 100.00% |
| Net Profit Margin | n/a | -9.06K% | -3.06K% | -993.83% |
| Pretax Profit Margin | n/a | -9.06K% | -3.06K% | -993.83% |
| Operating Profit Margin | n/a | -9.25K% | -3.06K% | -884.86% |
| FCF Margin | n/a | -8.48K% | -2.68K% | -604.35% |
| EBITDA Margin | n/a | -8.87K% | -3.06K% | -884.04% |